Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$2.18M Sell
13,278
-53
-0.4% -$8.81K 1.34% 17
2016
Q4
$1.95M Hold
13,331
1.24% 23
2016
Q3
$2.22M Sell
13,331
-1,150
-8% -$194K 1.36% 21
2016
Q2
$2.2M Buy
14,481
+550
+4% +$85.5K 1.36% 21
2016
Q1
$2.09M Sell
13,931
-169
-1% -$25.1K 1.18% 25
2015
Q4
$2.29M Hold
14,100
1.32% 19
2015
Q3
$1.95M Hold
14,100
1.22% 22
2015
Q2
$2.16M Sell
14,100
-292
-2% -$46.8K 1.23% 22
2015
Q1
$2.3M Hold
14,392
1.27% 19
2014
Q4
$2.29M Buy
+14,392
New +$2.24M 1.73% 13
2014
Q1
$2.3M Buy
+14,392
New +$1.75M 1.27% 19

Other funds holding AMGN

CT Financial Advisors's AMGN Position: Q1 2017 in Review

CT Financial Advisors reduced its Amgen (AMGN) stake by 0.4% in Q1 2017, selling an estimated $8.81K and leaving 13,278 shares worth $2.18M. The position accounts for 1.34% of the portfolio, ranked #17.

CT Financial Advisors first reported a position in AMGN in Q1 2014 and has held it in 11 quarters since. The position peaked at $2.3M in Q1 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • CT Financial Advisors held 13,278 shares of Amgen worth $2.18M as of Q1 2017.
  • CT Financial Advisors sold 53 Amgen shares in Q1 2017, an estimated $8.81K.
  • Amgen made up 1.34% of CT Financial Advisors's portfolio in Q1 2017, its #17 holding.
  • CT Financial Advisors first reported a position in Amgen in Q1 2014 and has held it in 11 quarters since.
  • CT Financial Advisors's Amgen position peaked at $2.3M in Q1 2015.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.